DJIA 16,262.56 89.32 0.55%
NASDAQ 4,034.16 0.00 0.00%
S&P 500 1,842.98 12.37 0.68%
market minute promo

Novavax, Inc.

NASDAQ: NVAX

3.69 -0.03 (-0.81%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVAX $3.69 -0.81%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.75
Previous Close $3.72
Daily Range $3.34 - $3.80
52-Week Range $1.68 - $6.95
Market Cap $771.4M
P/E Ratio -12.42
Dividend (Yield) $0.00 (0.0%)
Volume 5,513,713
Average Daily Volume 5,628,528
Current FY EPS -$0.27

Sector

Healthcare

Industry

Drugs

Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website: http://www.novavax.com/

News & Commentary Rss Feed

Are Inovio and Rockwell Medical In for a Bad Year?

These biopharmas have started the year poorly and could be in for a bad 2014.

Novavax: Promising Pipeline And Stable Revenue Add To Upside

Today's Dead Cat Bounce Stock: Novavax (NVAX)

Insiders And Analysts Like These Speculative Small Cap Stocks

5 Stocks With Big Insider Buying

Insider Trading Alert - UNP, OPK And NVAX Traded By Insiders

Novavax Is Now Oversold (NVAX)

Benzinga's Top #PreMarket Gainers

Novavax's CEO Discusses Q4 2013 Results - Earnings Call Transcript

After-Hours Earnings Report for March 10, 2014 : URBN, UNFI, CASY, NVAX, SMLP, PWRD, FCEL, EXK, POW

After-Hours Earnings Report for March 10, 2014 : URBN, UNFI, CASY, NVAX, SMLP, PWRD, FCEL, EXK, POWR, CISG, MED, PLOW

Earnings Expectations For The Week Of March 10: The Season Winds Down

See More NVAX News...

NVAX's Top Competitors

NVAX $3.69 (-0.81%)
Current stock: NVAX
AMGN $115.00 (1.48%)
Current stock: AMGN
GILD $68.17 (2.07%)
Current stock: GILD
BIIB $285.49 (2.14%)
Current stock: BIIB